Novel association patterns of cardiac remodeling markers in patients with essential hypertension and atrial fibrillation
- PMID: 22204652
- PMCID: PMC3276440
- DOI: 10.1186/1471-2261-11-77
Novel association patterns of cardiac remodeling markers in patients with essential hypertension and atrial fibrillation
Abstract
Background: Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) are essential for the cardiac extracellular matrix (ECM) remodeling. We investigated differences in serum levels of these markers between patients with atrial fibrillation (AF) and sinus rhythm (SR).
Methods: Serum levels of MMP-2, MMP-3, MMP-9 and TIMP-1 were measured in 86 patients: 27 on SR without any AF history, 33 with paroxysmal and 26 with permanent AF. All subjects had essential hypertension, normal systolic function and no coronary artery disease.
Results: Patients with AF had higher MMP-2, MMP-3 and MMP-9 and lower TIMP-1 compared to SR subjects (all p < 0.001). Paroxysmal AF was associated with higher MMP-2 levels compared to permanent AF (p < 0.001). Matrix metalloproteinase-9 but not MMP-3 was higher in permanent compared to paroxysmal AF group (p < 0.001). Patients with AF had lower levels of TIMP-1 compared to those with SR while permanent AF subjects had lower TIMP-1 levels than those with paroxysmal AF (p < 0.001 for both comparisons). Lower TIMP-1 was the only independent factor associated with AF (OR: 0.259, 95%CI: 0.104-0.645, p = 0.004).
Conclusions: In hypertensives, paroxysmal AF and permanent AF differ with respect to serum MMPs. Increased MMP-2 is associated with paroxysmal, whereas increased MMP-9 with permanent AF. Additionally, lower levels of TIMP-1 had a strong association with AF incidence.
Figures



Similar articles
-
The role of pro-fibrotic biomarkers in paroxysmal and persistent atrial fibrillation.Cytokine. 2018 Mar;103:63-68. doi: 10.1016/j.cyto.2017.12.026. Epub 2018 Jan 8. Cytokine. 2018. PMID: 29324263 Clinical Trial.
-
MMP-9 in atrial remodeling in patients with atrial fibrillation.Ann Cardiol Angeiol (Paris). 2015 Sep;64(4):285-91. doi: 10.1016/j.ancard.2014.12.004. Epub 2015 Jan 30. Ann Cardiol Angeiol (Paris). 2015. PMID: 25869465
-
Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation.Cardiovasc Res. 2005 Sep 1;67(4):655-66. doi: 10.1016/j.cardiores.2005.04.016. Cardiovasc Res. 2005. PMID: 15913581
-
Is thrombogenesis in atrial fibrillation related to matrix metalloproteinase-1 and its inhibitor, TIMP-1?Stroke. 2003 May;34(5):1181-6. doi: 10.1161/01.STR.0000065431.76788.D9. Epub 2003 Mar 27. Stroke. 2003. PMID: 12663879
-
[Changes in gelatinases expression and activity in human atria during atrial fibrillation].Zhonghua Xin Xue Guan Bing Za Zhi. 2005 Feb;33(2):137-42. Zhonghua Xin Xue Guan Bing Za Zhi. 2005. PMID: 15924808 Chinese.
Cited by
-
Cardioembolic stroke diagnosis using blood biomarkers.Curr Cardiol Rev. 2013 Nov;9(4):340-52. doi: 10.2174/1573403x10666140214122633. Curr Cardiol Rev. 2013. PMID: 24527683 Free PMC article. Review.
-
Biomarkers in electrophysiology: role in arrhythmias and resynchronization therapy.J Interv Card Electrophysiol. 2015 Jun;43(1):31-44. doi: 10.1007/s10840-015-9982-7. Epub 2015 Feb 27. J Interv Card Electrophysiol. 2015. PMID: 25715916 Free PMC article.
-
Novel fibro-inflammation markers in assessing left atrial remodeling in non-valvular atrial fibrillation.Med Sci Monit. 2014 Mar 21;20:463-70. doi: 10.12659/MSM.890635. Med Sci Monit. 2014. PMID: 24651058 Free PMC article.
-
The Role of Major Inflammatory Biomarkers in the Pathogenesis of Atrial Fibrillation.J Innov Card Rhythm Manag. 2022 Dec 15;13(12):5265-5277. doi: 10.19102/icrm.2022.13125. eCollection 2022 Dec. J Innov Card Rhythm Manag. 2022. PMID: 37293559 Free PMC article.
-
Novel association between plasma matrix metalloproteinase-9 and risk of incident atrial fibrillation in a case-cohort study: the Atherosclerosis Risk in Communities study.PLoS One. 2013;8(3):e59052. doi: 10.1371/journal.pone.0059052. Epub 2013 Mar 15. PLoS One. 2013. PMID: 23554968 Free PMC article.
References
-
- Sun H, Gaspo R, Leblanc N, Nattel S. Cellular mechanisms of atrial contractile dysfunction caused by sustained atrial tachycardia. Circulation. 1998;98(7):719–727. - PubMed
-
- Rizos I, Tsiodras S, Rigopoulos AG, Dragomanovits S, Kalogeropoulos AS, Papathanasiou S, Sakadakis EA, Kremastinos DT. Interleukin-2 serum levels variations in recent onset atrial fibrillation are related with cardioversion outcome. Cytokine. 2007;40(3):157–164. doi: 10.1016/j.cyto.2007.08.013. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous